Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07422298
PHASE1

A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants

Sponsor: Bristol-Myers Squibb

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the effect of BMS-986278 on the cardiac repolarization in healthy participants.

Official title: A Phase 1, Randomized, Double-blind, Positive-controlled, Placebo-controlled, 4-Period Crossover, Thorough QT/QTc Study to Evaluate the Effect of Multiple Doses of BMS-986278 on Cardiac Repolarization in Healthy Participants

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

32

Start Date

2026-02-19

Completion Date

2026-06-15

Last Updated

2026-03-17

Healthy Volunteers

Yes

Interventions

DRUG

BMS-986278

Specified dose on specified days

DRUG

Placebo

Specified dose on specified days

DRUG

Moxifloxacin

Specified dose on specified days

Locations (1)

Worldwide Clinical Trials

San Antonio, Texas, United States